# An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China

> **NCT03076580** · — · UNKNOWN · sponsor: **Beijing Institute of Heart, Lung and Blood Vessel Diseases** · enrollment: 2000 (estimated)

## Conditions studied

- Dilated Cardiomyopathy
- Hypertrophic Cardiomyopathy
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Left Ventricular Non-compaction
- Restrictive Cardiomyopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03076580
- **Lead sponsor:** Beijing Institute of Heart, Lung and Blood Vessel Diseases
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07-01
- **Primary completion:** 2018-07-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2018-04-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03076580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03076580, "An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03076580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*